Hepatology

Progressive familial intrahepatic cholestasis (PFIC) is a cholestatic condition that typically arises in childhood. As such, if an adult…

For patients with the chronic progressive liver disease primary biliary cholangitis (PBC), personalised treatment is key to both…

The management of liver cancer has changed dramatically during the 4 decades since I started as an internal medicine speciality fellow…

Portal hypertension is the major determinant of outcomes in patients with cirrhosis, defined as the presence of a hepatic venous pressure…

Zinc salts are one of three approved treatments for the autosomal recessive condition Wilson’s disease (WD). Their use was first described…

Peginterferon α-2b (Peg IFNα-2b), which inhibits viral replication in infected cells, suppresses cell proliferation, induces apoptosis, and…

Methotrexate (MTX), an antimetabolite, has a multifarious mechanism of action that most notably includes folate antagonism, effects on…

Anil Dhawan – Professor of Paediatric Hepatology, King’s College London, UK. I started in paediatric hepatology in 1992, when I got a…